• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性重度酒精性肝炎:临床特征和结局。

Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes.

机构信息

Department of Medicine, Brighton and Sussex Medical School, Brighton, UK.

出版信息

Eur J Gastroenterol Hepatol. 2013 Jun;25(6):659-64. doi: 10.1097/MEG.0b013e32835d83d9.

DOI:10.1097/MEG.0b013e32835d83d9
PMID:23628964
Abstract

BACKGROUND AND AIMS

Despite high recidivism rates in those treated for alcoholism, recurrent episodes of severe alcoholic hepatitis (SAH) have not been described. Our aim was to assess the clinical characteristics and outcomes in recurrent SAH.

PATIENTS AND METHODS

A retrospective review of patient records was carried out. Recurrent SAH was defined as two or more discrete episodes of SAH (discriminant function≥32) coinciding with recidivism in the same patient, with documented improvement/resolution of jaundice during intervening periods of abstinence.

RESULTS

Of 56 patients with recidivism following index presentation with SAH, 10 (17.9%) developed recurrent SAH. We report on 17 episodes in seven patients with complete data. The mean age and duration of alcohol use were 47.9±7.4 and 16.1±5.2 years, respectively. Compared with those without recurrence, the cohort with recurrent SAH were more likely to be women (57.1 vs. 34.8%, P=0.405), had higher alcohol consumption during relapse (16.0±15.3 vs. 11.3±8.1 U/day, P=0.591) and a recidivism pattern of alcohol relapse after initial abstinence rather than continuous alcohol use. Recurrent episodes were more severe compared with the index one (discriminant function 70.4±27.9 vs. 50.5±10.9; MELD score 26.2±3.7 vs. 22.1±1.5, P<0.05), the overall mortality being 57.1%. Treatment responses to corticosteroids were consistent in 66.7% of patients.

CONCLUSION

Approximately 18% of patients, especially women, develop recurrent SAH because of recidivism, with increasing disease severity and mortality approaching 60%. Our data underscore the urgent need to develop strategies to prevent recidivism following index presentation with SAH.

摘要

背景与目的

尽管酗酒患者的复发率很高,但尚未描述反复发生的严重酒精性肝炎(SAH)。我们的目的是评估复发性 SAH 的临床特征和结局。

患者与方法

对患者病历进行了回顾性审查。复发性 SAH 定义为同一患者出现两次或两次以上离散的 SAH 发作(判别函数≥32),同时伴有戒酒后黄疸缓解/消退的复发。

结果

在首次出现 SAH 后出现复发的 56 例患者中,有 10 例(17.9%)发生复发性 SAH。我们报告了 7 例患者中 17 个完整数据的发作。患者的平均年龄和饮酒时间分别为 47.9±7.4 岁和 16.1±5.2 年。与无复发的患者相比,复发性 SAH 组女性更多(57.1% vs. 34.8%,P=0.405),复发时的酒精摄入量更高(16.0±15.3 vs. 11.3±8.1 U/天,P=0.591),且复发性 SAH 的模式为初始戒酒后而非持续饮酒后酒精复发。复发性发作比首发更严重(判别函数 70.4±27.9 vs. 50.5±10.9;MELD 评分 26.2±3.7 vs. 22.1±1.5,P<0.05),总死亡率为 57.1%。皮质类固醇治疗的反应在 66.7%的患者中是一致的。

结论

大约 18%的患者,尤其是女性,由于复发而出现复发性 SAH,疾病的严重程度和死亡率均接近 60%。我们的数据强调了迫切需要制定策略来预防首次出现 SAH 后的复发。

相似文献

1
Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes.复发性重度酒精性肝炎:临床特征和结局。
Eur J Gastroenterol Hepatol. 2013 Jun;25(6):659-64. doi: 10.1097/MEG.0b013e32835d83d9.
2
Determinants of long-term outcome in severe alcoholic hepatitis.严重酒精性肝炎的长期预后因素。
Aliment Pharmacol Ther. 2013 Sep;38(6):584-95. doi: 10.1111/apt.12427. Epub 2013 Jul 23.
3
Early liver transplantation for severe alcoholic hepatitis.早期肝移植治疗严重酒精性肝炎。
N Engl J Med. 2011 Nov 10;365(19):1790-800. doi: 10.1056/NEJMoa1105703.
4
The management of alcoholic hepatitis: a prospective comparison of scoring systems.酒精性肝炎的治疗:评分系统的前瞻性比较。
Aliment Pharmacol Ther. 2013 Sep;38(6):603-10. doi: 10.1111/apt.12414. Epub 2013 Jul 23.
5
A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.第4天的里尔模型可预测重症酒精性肝炎患者对皮质类固醇的反应及死亡率。
Am J Gastroenterol. 2017 Feb;112(2):306-315. doi: 10.1038/ajg.2016.539. Epub 2016 Dec 6.
6
Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease.酒精性肝病肝移植后酒精和非法药物复吸的预测因素。
Transplantation. 2008 Oct 27;86(8):1090-5. doi: 10.1097/TP.0b013e3181872710.
7
The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.移植受体肝脏中的急性酒精性肝炎对肝移植术后结局的影响。
Liver Transpl. 2007 Dec;13(12):1728-35. doi: 10.1002/lt.21298.
8
Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism.酒精性肝病的原位肝移植:生存、复发及复发危险因素的回顾性分析
Liver Transpl. 2001 May;7(5):418-27. doi: 10.1053/jlts.2001.23789.
9
Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.使用OKT3与肝移植后丙型肝炎的早期和严重复发有关。
Am J Gastroenterol. 1997 Sep;92(9):1453-7.
10
Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis.循环白蛋白-胆红素复合物的分子椭圆率与重症酒精性肝炎患者的死亡率相关。
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1322-1332.e4. doi: 10.1016/j.cgh.2017.11.022. Epub 2017 Nov 16.

引用本文的文献

1
Sex differences in severity, outcomes, and healthcare utilization in alcohol-associated hepatitis.酒精性肝炎在严重程度、预后及医疗利用方面的性别差异。
World J Hepatol. 2025 Aug 27;17(8):108063. doi: 10.4254/wjh.v17.i8.108063.
2
Current and emerging therapies for alcohol-associated hepatitis.酒精性肝炎的现有及新兴疗法
Liver Res. 2023 Mar 15;7(1):35-46. doi: 10.1016/j.livres.2023.03.002. eCollection 2023 Mar.
3
Alcohol-Associated Hepatitis: Short- and Long-Term Management.酒精性肝炎:短期和长期管理
Dig Dis Sci. 2025 Jan;70(1):74-84. doi: 10.1007/s10620-024-08705-1. Epub 2024 Nov 22.
4
Soaring rates of alcohol-related hepatitis in the latter phase of the COVID-19 pandemic: A new normal?新冠疫情后期酒精性肝炎发病率飙升:一种新常态?
JGH Open. 2023 Jan 13;7(2):148-151. doi: 10.1002/jgh3.12864. eCollection 2023 Feb.
5
Increased mortality in patients with alcohol-induced pancreatitis during the COVID-19 pandemic.在新冠疫情期间,酒精性胰腺炎患者的死亡率上升。
Ann Gastroenterol. 2023 Jan-Feb;36(1):68-72. doi: 10.20524/aog.2022.0769. Epub 2022 Nov 29.
6
Moderate Alcoholic Hepatitis.中度酒精性肝炎。
Clin Liver Dis. 2021 Aug;25(3):537-555. doi: 10.1016/j.cld.2021.03.001. Epub 2021 May 27.
7
Con: Liver Transplantation Should Not Be Performed in Patients With Acute Alcoholic Hepatitis.反对观点:急性酒精性肝炎患者不应接受肝移植。
Clin Liver Dis (Hoboken). 2019 May 31;13(5):144-147. doi: 10.1002/cld.779. eCollection 2019 May.
8
Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis.在出院后 30 天内进行酒精康复治疗与酒精性肝炎患者的再入院率、复发率和死亡率降低相关。
Clin Gastroenterol Hepatol. 2020 Feb;18(2):477-485.e5. doi: 10.1016/j.cgh.2019.04.048. Epub 2019 Apr 28.
9
Immune checkpoint receptors: homeostatic regulators of immunity.免疫检查点受体:免疫的内稳态调节剂。
Hepatol Int. 2018 May;12(3):223-236. doi: 10.1007/s12072-018-9867-9. Epub 2018 May 8.
10
Concomitant Psychiatric and Nonalcohol-Related Substance Use Disorders Among Hospitalized Patients with Alcoholic Liver Disease in the United States.美国住院酒精性肝病患者合并精神疾病和非酒精相关物质使用障碍。
Alcohol Clin Exp Res. 2018 Feb;42(2):397-402. doi: 10.1111/acer.13567. Epub 2018 Jan 1.